Skip to main content
Log in

Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Molecular analyses allow one to determine genetic lesions occurring early in the development of tumors. With positional cloning approaches we are searching for a gene involved in the development of early onset familial breast and ovarian cancer that maps to human chromosome 17q21 and is termed BRCA1. This involves localizing the region genetically within families with multiply affected members, capturing the region identified by genetic analyses in YACs (yeast artificial chromosomes), converting those YACs to smaller manipulable pieces (such as cosmids), and searching for genes via a variety of approaches such as direct screening of cDNA libraries with genomic clones, direct selection by hybridization, “exon trapping”, and CpG island rescue. Once identified, candidate genes will be screened for mutations in affected family members in whom breast cancer segregates with the locus on 17q21. The frequency of this gene has been calculated to be 0.0033; from this the incidence of carriers, i.e. those carrying such a predisposition, is one in 150 women. The isolation of BRCA1 and the elucidation of the mutations resulting in breast and ovarian cancer predisposition will allow identification of women who have inherited germ-line mutations in BRCA1. In families known to harbor a germ-line BRCA1 mutation, diagnosis of affected members will be rapid. It is possible that one will also be able to detect alterations of the second copy of this gene early in tumor development in individuals carrying a germ-line mutation. It is not yet known how frequently somatic BRCA1 mutations predispose to breast and ovarian carcinoma in the general female population. If, as in other genetic diseases, new germ-line mutations occur in some women and thus contribute to the development of breast cancer, it may be feasible to screen women in the general population for predisposing mutations. In addition, if acquired genetic mutations of the BRCA1 gene are involved as early events in the development of non-familial forms of the disease, early detection of possible breast carcinoma may become feasible in biopsy of breast tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anderson L, Friedman L, Osborne-Lawrence S, et al: High-density genetic map of the BRCA1 region of chromosome 17q12-q21. Genomics 17:618–641, 1993

    Google Scholar 

  2. Ashton-Rickardt PG, Dunlop MG, Nakamura Y, Morris RG, Purdie CA, Steel CM, Evans HJ, Bird CC, Wyllie AH: High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene 4:1169–1174, 1989

    Google Scholar 

  3. Bates G, Valdes J, Hummerich H, Baxendale S, Le Paslier D, Monaco A, Tagle D, MacDonald M, Altherr M, Ross M, Brownstein B, Bentley D, Wasmuth J, Gusella J, Cohen D, Collins F, Lehrach H: Characterization of a yeast artificial chromosome contig spanning the Huntington's disease gene candidate region. Nature Genet 1:180–187, 1993

    Google Scholar 

  4. Bird A: CpG islands as gene markers in the vertebrate nucleus. Trends Genet 3:342–347, 1987

    Google Scholar 

  5. Bishop J, Morton J, Rosebach M, Richardson M: Three abundance classes in HeLa cell messenger RNA. Nature 250:199–204, 1974

    Google Scholar 

  6. Bowcock A, Anderson L, Black D, Osborne-Lawrence S, Hall J, King M-C: THRA1 and D17S183 flank an interval of < 4cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet 52:718–722, 1993

    Google Scholar 

  7. Buckler A, Chang D, Graw S, et al: Exon amplification: A strategy to isolate mammalian genes based on RNA splicing. Proc Natl Acad Sci USA 88:4005–4009, 1991.

    Google Scholar 

  8. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S, Nordenskjold M: Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968–1972, 1990

    Google Scholar 

  9. Chumakov IF, Rigault P, Guillou S, Ougen P, Billaut A, Guasconi G, et al: Continuum of overlapping clones spanning the entire human chromosome 21q. Nature 359:380–387, 1992

    Google Scholar 

  10. Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232–242, 1991

    Google Scholar 

  11. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS: Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301:592–595, 1979

    Google Scholar 

  12. Cotton RG, Rodrigues NR, Campbell RD: Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci USA 85:4397–4401, 1988

    Google Scholar 

  13. Cox DR, Burmeister M, Price ER, Kim S, Myers RM: Radiation hybrid mapping: a somatic cell genetic method for constructing high resolution maps of mammalian chromosomes. Science 250:245–250, 1990

    Google Scholar 

  14. Duyk G, Kim S, Myers R, Cox D: Exon trapping: A genetic screen to identify candidate transcribed sequences in cloned mammalian genomic DNA. Proc Natl Acad Sci USA 87:8995–8999, 1990

    Google Scholar 

  15. Easton DF, Bishop T, Ford D, Crockford GP: The Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678–701, 1993

    Google Scholar 

  16. Fontaine B, Sanson M, Delattre O, Menon AG, Rouleau GA, Seizinger BR, Jewell AF, Hanson MP, Aurias A, Martuza RL, et al: Parental origin of chromosome 22 loss in sporadic and NF2 neuromas. Genomics 10:280–283, 1991

    Google Scholar 

  17. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49–56, 1990

    Google Scholar 

  18. Futreal PA, Söderqvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW: Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52:2624–2627, 1992

    Google Scholar 

  19. Galau G, Klein W, Britten R, Davidson E: Significance of rare mRNA sequences in liver. Arch Biochem Biophys 179:584–599, 1977

    Google Scholar 

  20. Green ED, Olson MV: Systematic screening of yeast artificial-chromosome libraries by use of the polymerase chain reaction. Proc Natl Acad Sci USA 87:1213–1217, 1990

    Google Scholar 

  21. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Yoslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, LePaslier D, Abderrahim H, Cohen D, Leppert M, White R: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600, 1991

    Google Scholar 

  22. Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689, 1990

    Google Scholar 

  23. Herrera L: Gardner's syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25:473–476, 1986

    Google Scholar 

  24. Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease. Cell 72:971–983, 1993

    Google Scholar 

  25. Jelinek WR: Ubiquitous interspersed repeated sequences in mammalian genomes. Proc Natl Acad Sci USA 77:1398–1402, 1980

    Google Scholar 

  26. Kelsey JL: A review of the epidemiology of human breast cancer. Epidemiol Rev 1:74–109, 1979

    Google Scholar 

  27. Kovacs G, Szucs S, De Riese W, Baumgartel H: Specific chromosome aberration in human renal cell carcinoma. Cancer Res 40:171–178, 1987

    Google Scholar 

  28. Ledbetter SA, Nelson DL, Warren ST, Ledbetter DH: Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction. Genomics 6:475–481, 1990

    Google Scholar 

  29. Lovett M, Kere J, Hinton L: Direct selection: A method for the isolation of cDNAs encoded by large genomic regions. Proc Natl Acad Sci USA 88:9628–9633, 1991

    Google Scholar 

  30. Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238, 1990

    Google Scholar 

  31. Margaritte P, Bonaiti-Pellie C, King M-C, Clerget-Darpoux F: Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease: Am J Hum Genet 50:1231–1234, 1992

    Google Scholar 

  32. Milner R, Lai C, Lenoir D, Nave K, Bakhit C, Malfroy B: Brain-specific gene expression. Biochem Soc Symp 52:107–117, 1986

    Google Scholar 

  33. Myers RM, Sheffield VC, Cox DR: Detection of single base changes in DNA: ribonuclease cleavage and denaturing gradient gel electrophoresis.In: Davies K (ed) Genome Analysis: A Practical approach. IRL Press, 1988, pp 95–130

  34. Narod S, Feunteun J, Lynch H, et al: Familial breastovarian cancer locus on chromosome 17q12-q23. Lancet 338:82–83, 1991

    Google Scholar 

  35. Newman B, Austin M, Lee M, King M: Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:3044–3048, 1988

    Google Scholar 

  36. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preisinger AC, Smith KJ, Su L, Kinzler KW, Vogelstein B: Mutations of chromosome 5q21 genes in FAP patients and colorectal cancer patients. Science 253:665–669, 1991

    Google Scholar 

  37. Olson M, Hood L, Cantor C, Botstein D: A common language for physical mapping of the human genome. Science 245:1434–1435, 1989

    Google Scholar 

  38. Ohlsson R: Growth factors, proto-oncogenes and human placental development. Cell Diff Dev 28:1–15, 1989

    Google Scholar 

  39. Okubo K, Hori N, Matoba R, et al: Large-scale cDNA mapping for analysis of quantitative and qualitative aspects of gene-expression. Nature Genet 2:173–179, 1992

    Google Scholar 

  40. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766–2770, 1989

    Google Scholar 

  41. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879, 1989

    Google Scholar 

  42. Parimoo S, Patanjali S, Shukla H, Chaplin D, Weismann S: cDNA selection: efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. Proc Natl Acad Sci USA 88:9623–9627, 1991

    Google Scholar 

  43. Pathak S, Strong LC, Ferrell RE, Trindade A: Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. Science 217:939–941, 1982

    Google Scholar 

  44. Ponder BAH: Gene losses in human tumours. Nature 335:400–401, 1988

    Google Scholar 

  45. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555–7559, 1990

    Google Scholar 

  46. Rommens JM, Iannuzzi MC, Kerem B, Drunn ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui L-C, Collins FS: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065, 1989

    Google Scholar 

  47. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y: Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184–7189, 1990

    Google Scholar 

  48. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y: Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51:5794–5799, 1991

    Google Scholar 

  49. Saito H, Inazawa J, Saito S, Kasumi F, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y: Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 53:3382–3385, 1993

    Google Scholar 

  50. Schwartz DC, Cantor CR: Separation of yeast chromosome-sized DNAs by pulsed-field gradient gel electrophoresis. Cell 37:67–75, 1984

    Google Scholar 

  51. Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, Anderson KM, Freiman RN, Whaley J, et al: Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. Proc Natl Acad Sci USA 88:2864–2868, 1991

    Google Scholar 

  52. Simard J, Feunteun J, Lenoir G, Tonin P, Normand T, Luu The V, Vivier A, Lasko D, Morgan K, Rouleau GA, Lynch H, Labrie F, Narod SA: Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum Molec Genet 2:1193–1199, 1993

    Google Scholar 

  53. Slamon DJ, Godolphin W, Jones LA, et al: Studies of the HER-2/neu oncogene. Science 235:177–182, 1989

    Google Scholar 

  54. Smith S, Easton D, Evans D, Bonder B: Allele losses in the region 17q12-q21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet 2:128–131, 1992

    Google Scholar 

  55. Tsui LC: The spectrum of cystic fibrosis mutations [review]. Trends in Genetics 8:392–398, 1992

    Google Scholar 

  56. Trask BJ: Fluorescencein situ hybridization: applications in cytogenetics and gene mapping. Trends in Genetics 7:149–154, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowcock, A.M. Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer. Breast Cancer Res Tr 28, 121–135 (1993). https://doi.org/10.1007/BF00666425

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00666425

Key words

Navigation